eli lilly retatrutide study just released impressive results for retatrutide, an investigational weight loss drug that targets three hormones—and may deliver more weight loss than current GLP-1s. See link below ⬇️ 🚀Eli Lilly Announces Positive Phase

Hormone and glucose signalling in POMC and AgRP neurons

Some patients require slower titration due to sensitivity, while others can advance at the standard schedule

[21] has been used in the semaglutide phase III development program, in which semaglutide showed a gastrointestinal AE profile comparable to that of other GLP-1 receptor agonists [23]

Pregnant or Breastfeeding Women: The increased nutritional needs during pregnancy and breastfeeding may require B12 supplementation to support both mother and child

A balanced diet rich in whole foods, fruits, vegetables, and lean proteins complements the potential benefits of Eqvp GLP-1

Josselyn, S